AptarGroup
🇺🇸 NYSE:ATR
•
Dec 31, 2024
AptarGroup Q4 2024 Earnings Report
Key Takeaways
Aptar reported strong Q4 results with net income surging 62% year-over-year, driven by increased demand in pharma and closures segments. Adjusted EPS rose 27% while core sales grew 2%.
AptarGroup Revenue
AptarGroup EPS
AptarGroup Revenue by Segment
Forward Guidance
Aptar expects continued earnings growth in 2025, led by pharma, but anticipates foreign exchange headwinds and higher tax rates in Q1.
Positive Outlook
- Pharma segment expected to drive future growth
- Proprietary drug delivery systems showing strong demand
- Cost containment efforts improving margins
- Strong cash flow generation supporting investments
- Share repurchase authorization provides capital return flexibility
Challenges Ahead
- Stronger U.S. dollar causing currency headwinds
- Higher tax rate expected in Q1 2025
- Softer demand anticipated in certain end markets
- Potential impact from geopolitical uncertainties
- Economic volatility could affect consumer demand
Revenue & Expenses
Visualization of income flow from segment revenue to net income